Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 61 AL 75

A systematic review and meta-analysis of transcranial direct-current stimulation effects on cognitive function in patients with Alzheimer's disease

Majdi A, van Boekholdt L, Sadigh-Eteghad S, Mc Laughlin M.

Mol Psychiatry. 2022 Apr;27(4):2000-2009. doi: 10.1038/s41380-022-01444-7. Epub 2022 Feb 3.

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis

Shukla M, Wongchitrat P, Govitrapong P.

Neurochem Res. 2022 May;47(5):1166-1182. doi: 10.1007/s11064-022-03530-2. Epub 2022 Feb 5.

What have we learnt from past failures in Alzheimer's disease drug discovery?

Cacabelos R.

Expert Opin Drug Discov. 2022 Apr;17(4):309-323. doi: 10.1080/17460441.2022.2033724. Epub 2022 Feb 6.

Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey

DiStefano MJ, Alexander GC, Polsky D, Anderson GF.

J Am Geriatr Soc. 2022 Jun;70(6):1685-1694. doi: 10.1111/jgs.17692. Epub 2022 Feb 7.

Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings

Khezri MR, Yousefi K, Mahboubi N, Hodaei D, Ghasemnejad-Berenji M.

Biochem Pharmacol. 2022 Mar;197:114945. doi: 10.1016/j.bcp.2022.114945. Epub 2022 Feb 5.

Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease

Xi M, Sun T, Chai S, Xie M, Chen S, Deng L, Du K, Shen R, Sun H.

Eur J Med Chem. 2022 Mar 15;232:114170. doi: 10.1016/j.ejmech.2022.114170. Epub 2022 Feb 3.

Can We Use Ginkgo biloba Extract to Treat Alzheimer's Disease? Lessons from Preclinical and Clinical Studies

Xie L, Zhu Q, Lu J.

Cells. 2022 Jan 29;11(3):479. doi: 10.3390/cells11030479.

Physical Activity Improves Cognition and Activities of Daily Living in Adults with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Zhou S, Chen S, Liu X, Zhang Y, Zhao M, Li W.

Int J Environ Res Public Health. 2022 Jan 22;19(3):1216. doi: 10.3390/ijerph19031216.

Medicine-Food Herbs against Alzheimer's Disease: A Review of Their Traditional Functional Features, Substance Basis, Clinical Practices and Mechanisms of Action

Guo P, Zhang B, Zhao J, Wang C, Wang Z, Liu A, Du G.

Molecules. 2022 Jan 28;27(3):901. doi: 10.3390/molecules27030901.

The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease

Shen S, Liao Q, Wong YK, Chen X, Yang C, Xu C, Sun J, Wang J.

Int J Biol Sci. 2022 Jan 1;18(3):983-994. doi: 10.7150/ijbs.66871. eCollection 2022.

Small molecules targeting γ-secretase and their potential biological applications

Wen J, Liu D, Zhao L.

Eur J Med Chem. 2022 Mar 15;232:114169. doi: 10.1016/j.ejmech.2022.114169. Epub 2022 Feb 1.

Costs associated with treatment of insomnia in Alzheimer's disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia

Bentley TGK, Castillo D, Sadeghi N, Piber D, Carroll J, Olmstead R, Irwin MR.

BMC Health Serv Res. 2022 Feb 19;22(1):231. doi: 10.1186/s12913-022-07619-w.

Effects of Resveratrol Supplementation on the Cognitive Function of Patients with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials

Tosatti JAG, Fontes AFDS, Caramelli P, Gomes KB.

Drugs Aging. 2022 Apr;39(4):285-295. doi: 10.1007/s40266-022-00923-4. Epub 2022 Feb 21.

Promising heterocycle-based scaffolds in recent (2019-2021) anti-Alzheimer's drug design and discovery

Dorababu A.

Eur J Pharmacol. 2022 Apr 5;920:174847. doi: 10.1016/j.ejphar.2022.174847. Epub 2022 Feb 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias